Robuta

https://www.businesswire.com/news/home/20211122005952/en/Pear-Therapeutics-Receives-FDA-Breakthrough-Device-Designation-for-Prescription-Digital-Therapeutic-Candidate-to-Treat-Alcohol-Use-Disorder
Pear Therapeutics Receives FDA Breakthrough Device Designation for Prescription Digital Therapeutic Candidate to Treat Alcohol Use Disorder
fda breakthrough devicepeartherapeuticsreceivesdesignation